Thursday, April 27, 2017
Tags Biomedical

Tag: biomedical


Popular Articles

Gerding Edlen beats initial target for Fund III with a $426m final close

Real estate investor Gerding Edlen Investment Management has closed its third fund on $416m.

VC dealmaking in Israel slumps to lowest point in two years, fears rise of...

Venture capital-backed dealmaking in Israel hit its lowest point since early 2015 last quarter with just $577m invested across 68 transactions, new research shows.

NorthEdge Capital backs Future Industrial Services

UK private equity firm NorthEdge Capital has made an investment in industrial services specialist Future Industrial Services (FIS).

Industrial Growth Partners taps Fund V to acquire Royal Die & Stamping

Industrial Growth Partners has tapped Fund V for the fourth time to acquire Royal Die & Stamping.

PGIM Real Estate collects more than £1bn for Fund VI final close

PGIM Real Estate, which recently rebranded from Pramerica Real Estate Capital, has raised more than £1bn for its latest fund.

Accolade closes oversubscribed sixth fund of funds on $235m

Venture capital and growth equity fund of funds investor Accolade Partners has pulled in $235m for the final close of its oversubscribed sixth fund.

Olympus said to eye potential $900m sale of Phoenix Services

Olympus Partners is reportedly exploring a sale of steel mill support solutions business Phoenix Services.

New York State Common Retirement backs KKR Asian Fund III

The New York State Common Retirement Fund (CRF) has spread $875m across five funds, including KKR & Co’s latest Asia vehicle.

VW’s Ducati could head back to private equity ownership

Volkswagen-owned performance motorbike manufacturer Ducati could reportedly be heading back into private equity hands after five years as part of the carmaker.

Cerberus said to continue Seibu selldown with up to $446m stake sale

US distressed investment firm Cerberus is reportedly continuing its selldown of Japanese railway, bus and hotel business Seibu Holdings with a stake sale of up to $446m.